It is important to pay tribute, because there are two elements to this: getting the capacity up is half of it, and we are making good progress—I hope that the right hon. and learned Gentleman concedes that point—and the issue of increasing the demand, which is something we have control over. Of course we are making sure that the eligibility is broadened. Our focus, as I think he would agree, should be on frontline NHS staff, broadened out to care workers and other key workers in a way that the system can manage. We are confident that, based on our test capacity, we will be able to deliver that. On the capacity itself reaching the 100,000 target, we have a range of deals with firms such as Randox, or AstraZeneca, GSK and Cambridge University working together to staff a new lab. We will deliver, and those tests will be crucial, not just to control the virus but to allow the country to move the next phase.